HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mingming Fang Selected Research

Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)

6/2019MKL1 mediates TNF-α induced pro-inflammatory transcription by bridging the crosstalk between BRG1 and WDR5.
12/2018Megakaryocytic Leukemia 1 Bridges Epigenetic Activation of NADPH Oxidase in Macrophages to Cardiac Ischemia-Reperfusion Injury.
4/2015Megakaryocytic leukemia 1 directs a histone H3 lysine 4 methyltransferase complex to regulate hypoxic pulmonary hypertension.
7/2013Megakaryocytic leukemia 1 (MKL1) ties the epigenetic machinery to hypoxia-induced transactivation of endothelin-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mingming Fang Research Topics

Disease

10Neoplasms (Cancer)
11/2019 - 02/2012
7Hypoxia (Hypoxemia)
01/2021 - 12/2011
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 09/2015
5Fibrosis (Cirrhosis)
01/2021 - 03/2015
5Inflammation (Inflammations)
03/2017 - 05/2009
4Neoplasm Metastasis (Metastasis)
09/2021 - 01/2019
4Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
06/2019 - 07/2013
3Hypertrophy
01/2021 - 03/2015
3Cardiomegaly (Heart Hypertrophy)
01/2020 - 03/2015
3Atherosclerosis
05/2014 - 05/2009
2Lung Neoplasms (Lung Cancer)
11/2019 - 01/2019
2Reperfusion Injury
12/2018 - 01/2017
2Myocardial Infarction
12/2018 - 01/2017
2Ischemia
12/2018 - 01/2018
2Alcoholic Fatty Liver
01/2018 - 07/2016
2Type 2 Diabetes Mellitus (MODY)
07/2015 - 02/2012
2Pulmonary Hypertension
04/2015 - 07/2013
2Atherosclerotic Plaque (Atheroma)
05/2014 - 11/2012
1Lymphatic Metastasis
09/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2021
1Heart Failure
01/2020
1Cardiovascular Diseases (Cardiovascular Disease)
01/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2019
1Multiple Myeloma
10/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Glioblastoma (Glioblastoma Multiforme)
01/2019
1Pathologic Processes
01/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Breast Neoplasms (Breast Cancer)
01/2019
1Ischemic Stroke
08/2017
1Brain Ischemia (Cerebral Ischemia)
08/2017
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2017
1Vascular System Injuries
01/2017
1Non-alcoholic Fatty Liver Disease
01/2017
1Insulin Resistance
07/2015
1Hyperglycemia
07/2015
1Diabetic Nephropathies (Diabetic Nephropathy)
07/2015

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2014
9Sirtuin 1IBA
01/2017 - 12/2011
7Histones (Histone)IBA
06/2019 - 07/2009
6CytokinesIBA
03/2017 - 05/2009
5myocardinIBA
01/2020 - 03/2015
5Transcription Factors (Transcription Factor)IBA
01/2020 - 03/2015
5MethyltransferasesIBA
06/2019 - 04/2015
4Angiotensin IIIBA
01/2021 - 03/2015
4Small Interfering RNA (siRNA)IBA
11/2019 - 01/2016
3Histone Acetyltransferases (Histone Acetyltransferase)IBA
01/2021 - 01/2020
3Pharmaceutical PreparationsIBA
11/2019 - 01/2014
3Biological ProductsIBA
01/2019 - 01/2014
3Interferon-gamma (Interferon, gamma)IBA
02/2016 - 05/2014
3Collagen Type I (Type I Collagen)IBA
07/2015 - 11/2012
2Thioacetamide (Thioacetamid)IBA
01/2020 - 02/2016
2Fatty Acids (Saturated Fatty Acids)IBA
01/2019 - 07/2015
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2017 - 01/2016
2Oxygen (Dioxygen)IBA
01/2017 - 04/2015
2PPAR gammaIBA
01/2017 - 05/2009
2Endothelins (Endothelin)IBA
05/2015 - 03/2015
2alpha2 Subunit Collagen Type IIBA
05/2014 - 11/2012
2CollagenIBA
11/2012 - 07/2009
1Chloride Channels (Chloride Channel)IBA
01/2021
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2020
1Cyclin B1IBA
11/2019
1Carrier Proteins (Binding Protein)IBA
11/2019
1Tripartite Motif ProteinsIBA
10/2019
1Tight Junction ProteinsIBA
01/2019
1CurcuminIBA
01/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2019
1ClaudinsIBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1AndrogensIBA
01/2019
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2019
1Interleukin-22 (IL-22)IBA
01/2019
1Fatty Acid ElongasesIBA
01/2019
1CCG 1423IBA
12/2018
1NADPH Oxidases (NAD(P)H oxidase)IBA
12/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2018
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2018
1Choline (Choline Chloride)IBA
01/2018
1Methionine (L-Methionine)FDA Link
01/2018
1LipidsIBA
01/2018
1AntioxidantsIBA
08/2017
1Neuroprotective AgentsIBA
08/2017
1Toll-Like Receptor 4IBA
08/2017
1Tissue Kallikreins (Tissue Kallikrein)IBA
08/2017
1Messenger RNA (mRNA)IBA
07/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2017
1Histone Deacetylases (Histone Deacetylase)IBA
01/2017
1Matrix Metalloproteinases (MMPs)IBA
01/2017
1Histone MethyltransferasesIBA
01/2017
1Inflammation MediatorsIBA
07/2016
1Trans-Activators (Trans-Acting Factor)IBA
02/2016
1A-Form DNA (A-DNA)IBA
01/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2015
1Extracellular Matrix ProteinsIBA
07/2015
1MHC class II transactivator proteinIBA
07/2015
1Lysine (L-Lysine)FDA Link
04/2015
1Cell Adhesion MoleculesIBA
04/2015
1Celecoxib (Celebrex)FDA Link
01/2014

Therapy/Procedure

3Drug Therapy (Chemotherapy)
09/2021 - 01/2014
1Radiotherapy
09/2021